Advertisement

Topics

U.S. Stem Cell, Inc. Company Profile

01:44 EDT 23rd April 2018 | BioPortfolio

U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell-based therapies that prevent or treat disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.


News Articles [2034 Associated News Articles listed on BioPortfolio]

U.S. Stem Cell, Inc.: U.S. Stem Cell Responds to FDA's Regenerative Medicine Guidelines

SUNRISE, FL / ACCESSWIRE / November 21, 2017 / U.S. Stem Cell, Inc. (OTCQB: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine so...

FDA Warns About Stem Cell Therapies

Stem cells have been called everything from cure-alls to miracle treatments. But don't believe the hype. The U.S. Food and Drug Administration is concerned that some patients may be vulnerable to stem...

Tiny stem cell companies close in on major heart disease goals

The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp aband...

The impact of adhesion molecules on the in vitro culture and differentiation of stem cells

The term "cell adhesion" represents cell‐cell interactions and the interaction between the cell and the extracellular matrix (ECM). These interactions are crucial for the development of the stem cel...

Global Animal Stem Cell Therapy Market Data List by Segment 20152022 [Report Updated: 16112017] Prices from USD $800

SnapshotAnimal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful f...

Confronting unproven stem cell treatments in Australia: The new regulation

Stem cell research holds tremendous promise for the treatment of a wide variety of illnesses and conditions, from spinal cord injury to autism. However, much more work is necessary to translate stem c...

FDA Sets Path for Stem Cell Therapies

(CNN) – Just months after the US Food and Drug Administration announced efforts to crack down on stem cell clinics touting unapproved therapies, the agency now plans to help expedite the develop...

Stem Cell Therapy for Crohn’s Disease Approved in Europe

Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe.  The European Commission has approved Alofisel (darvadstro...

PubMed Articles [5069 Associated PubMed Articles listed on BioPortfolio]

Tracing Stem Cell Division in Adult Neurogenesis.

Neural stem cells in the ventricular-subventricular zone of the adult brain continuously generate differentiated neurons without depleting the stem cell pool. In this issue of Cell Stem Cell, Obernier...

Orchestrating Ribosomal Subunit Coordination to Control Stem Cell Fate.

The mechanisms responsible for maintaining ribosomal component stoichiometry, which is critical during cell fate transitions, are currently not well understood. In this issue of Cell Stem Cell, Corsin...

Covering the Stem Cell Explosion at the 2017 ISSCR Conference in Boston.

The meeting covered a plethora of rapidly evolving approaches and areas, such as organoid cultures modeling tissues and organs; stem cell-specific metabolites revealing new signaling pathways; single-...

Intra-articular Mesenchymal Stem Cell Therapy for the Human Joint: A Systematic Review.

Stem cell therapy is emerging as a potential treatment of osteoarthritis (OA) and chondral defects (CDs). However, there is a great deal of heterogeneity in the literature. The indications for stem ce...

Insight into stem cell regulation from sub-lethally irradiated worms.

Despite the significant advances in the comprehension of stem cell control network, the nature of extrinsic signals regulating their dynamic remains to be understood. In this paper, we take advantage ...

Clinical Trials [7125 Associated Clinical Trials listed on BioPortfolio]

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

The investigators hypothesize that this study will show that sufficient lymphocyte stem cell can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5 of ...

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

The purpose of this study is to find out if getting a blood stem cell transplant with donor stem cells given over several days is better than getting a blood stem cell transplant with dono...

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is compari...

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune ...

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

The purpose of this study is to evaluate whether virus-specific T cell lines (VSTs) are safe and can effectively control three viruses (EBV, CMV, and adenovirus) in patients who have had a...

Companies [1052 Associated Companies listed on BioPortfolio]

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...

National Stem Cell Foundation

The National Stem Cell Foundation (NSCF) is a charitable 501(c)3 organization that funds adult stem cell and regenerative medicine research to accelerate treatment options, advoca...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

The New York Stem Cell Foundation

The New York Stem Cell Foundation (NYSCF) is an independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF, ...

International Society for Stem Cell Research

The International Society for Stem Cell Research is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of informati...

More Information about "U.S. Stem Cell, Inc." on BioPortfolio

We have published hundreds of U.S. Stem Cell, Inc. news stories on BioPortfolio along with dozens of U.S. Stem Cell, Inc. Clinical Trials and PubMed Articles about U.S. Stem Cell, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of U.S. Stem Cell, Inc. Companies in our database. You can also find out about relevant U.S. Stem Cell, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...


Corporate Database Quicklinks



Searches Linking to this Company Record